HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

PR-171

epoxomicin derivative proteasome inhibitor with antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells
Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Provaznikova, Dana: 1 article (03/2009)
2. Fuchs, Ota: 1 article (03/2009)
3. Spicka, Ivan: 1 article (03/2009)
4. Marinov, Iuri: 1 article (03/2009)
5. Kuzelova, Katerina: 1 article (03/2009)
6. Aujay, Monette A: 1 article (07/2007)
7. Kirk, Christopher J: 1 article (07/2007)
8. Vallone, Marcy K: 1 article (07/2007)
9. Jiang, Jing: 1 article (07/2007)
10. Molineaux, Christopher J: 1 article (07/2007)

Related Diseases

1. Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
2. Multiple Myeloma
3. Leukemia
4. Hematologic Neoplasms (Hematological Malignancy)
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. Proteasome Endopeptidase Complex (Proteasome)
2. carfilzomib
3. salinosporamide A
4. bortezomib (Velcade)
5. Histone Deacetylase Inhibitors
6. Valproic Acid (Valproate, Semisodium)
7. N- (2- aminophenyl)- 4- (N- (pyridin- 3- ylmethoxycarbonyl)aminomethyl)benzamide (MS 275)
8. benzamide

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)